Original ResearchExploratory analysis of biomarkers associated with clinical outcomes from the study of lenvatinib in differentiated cancer of the thyroid
Under a Creative Commons license
open access
Keywords
Lenvatinib
Biomarkers
Thyroid cancer
Tyrosine kinase inhibitor
Phase 3
Clinical trial
Cited by (0)
- 1
Present address: Division of Endocrinology and Nephrology, University of Leipzig, Leipzig, Germany.
© 2017 The Authors. Published by Elsevier Ltd.